Stellanine-PEG (Stellanin-PEG)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspOintment for external use.
Composition:
in 100 g of ointment:
Active substance:
1,3-diethylbenzimidazolium triiodide 3.0 g
(OOO PharmPreparat, Russia)
Excipients:
povidone (polyvinylpyrrolidone low molecular weight) K-17 2.0 g;
(FS 42-0117-03 or USP / NF)
Dimethyl sulfoxide (dimexide) 5.0
(FS 42-2980-98)
Macrogol 1500
(Polyethylene oxide 1500,
Polyethylene glycol 1500)
(FS 42-1885-95 or TU 2483-008-71150986-2006)
Macrogol 400 65.0 g.
(Polyethylene oxide 400, polyethylene glycol 400)
(FS 42-1242-96 or TU 2483-007-71150986-2006)
Description:Ointment is dark brown with a weak characteristic odor.
Pharmacotherapeutic group:Regeneration of tissue stimulant
Pharmacodynamics:The mechanism of pharmacological activity of the drug is the antibacterial action of 1,3-diethylbenzimidazolium. Active iodine, which is part of 1,3-diethylbenzimidazolium triiodide, inactivates the bacterial wall proteins and enzyme proteins of bacteria, thus having a bactericidal effect on microorganisms.
The pronounced antimicrobial effect of the drug prevents infection of the wounds.
Along with antibacterial and anti-inflammatory effects, ointment has a high osmotic potential, which is especially important in the treatment of purulent wounds, t. facilitates the evacuation of a wound defect purulent discharge.
Pharmacokinetics:Systemic absorption of the active substance is absent even with damaged skin, however, therapeutic concentrations of the drug are present in the wound.
Indications:
- treatment of acute purulent processes (wounds) of the skin and soft tissues (boils, carbuncles, hydroadenites, phlegmon, abscesses).
- additional treatment of suppurative complications of postoperative wounds (after excision, coagulation, episiotomy, for the treatment of cracks in the skin, wounds and sutures);
- thermal damage to the skin and soft tissues of I-III degrees, complicated by the infectious process.
- trophic ulcers, pressure sores, complicated by the infectious process.
- abrasions, cuts, scratches, cracks, scratching.
Contraindications:Hypersensitivity to the drug components, thyrotoxicosis, thyroid adenoma, renal failure, simultaneous therapy with radioactive iodine, children under 18 years, I trimester of pregnancy.
Carefully:Chronic renal failure, II and III trimesters of pregnancy, lactation.
Pregnancy and lactation:The use of the drug during the first trimester of pregnancy is contraindicated. Use with caution during the II and III trimesters of pregnancy.
Dosing and Administration:
The drug is applied a thin layer of about 1.5-2 mm directly on the wound surface, after which a sterile gauze dressing is applied,or the drug is applied to the dressing, and then to the wound. The layer of the ointment should exceed the circumference of the wound by at least 5 mm. Tampons impregnated with ointment loosely fill the cavities of purulent wounds after their surgical treatment, and the gauze turundas with the drug are injected into the fistulous passages. If the wound is localized on an uncomfortable place for bandaging, it is acceptable to use a band-aid or glue bandage. Change dressings produced 1-2 times a day.
The daily dose should not exceed 10 g. The duration of treatment on average is 5-15 days.
For minor skin lesions (abrasions, cuts, scratches, cracks, scratching), the drug is applied a thin layer on the affected surface 2 times a day.
Side effects:In rare cases, skin allergic reactions (pruritus, skin hyperemia) are possible, at the appearance of which it is necessary to stop the use of the drug.
Overdose:Cases of overdose are not described. With occasional ingestion of the drug, nausea and vomiting may occur. It is necessary to rinse the stomach and consult a doctor, if necessary, perform symptomatic treatment.
Interaction:Do not use the drug in combination with other antiseptic agents containing mercury, oxidants, alkalis and cationic surfactants. Alkaline or acidic medium, the presence of fat, pus, blood weaken antiseptic activity.
Special instructions:Avoid getting ointment in the eyes. If the product gets into the eyes, rinse with warm water.
Form release / dosage:Ointment for external use 3%.
Packaging:For 20 g in aluminum tubes together with instructions for use in packs of cardboard.
Storage conditions:
In a dry, the dark place at a temperature of 0-25 ° C.
Keep out of the reach of children
Shelf life:
2 years.
Do not use after the expiration date printed on the package.
Terms of leave from pharmacies:On prescription
Registration number:LSR-002113/09
Date of registration:19.03.2009 / 03.12.2015
The owner of the registration certificate:FARMPREPARAT, LLC FARMPREPARAT, LLC Russia
Manufacturer: & nbsp
Information update date: & nbsp20.01.2016
Illustrated instructions
    Instructions
    Up